Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Detailed history and physical examination are crucial for diagnosing hair loss.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

Some women with common hair loss may develop permanent hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Different hair loss types need accurate diagnosis for proper treatment.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.